Quantcast

Latest Tumor markers Stories

2012-04-09 21:46:42

Discovery of inherited-genetic variations may help assess a patient's risk of life-threatening disease before it strikes An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer. The findings, published online today in the Proceedings of the National Academy of Sciences (PNAS), indicate a man's risk of developing prostate cancer either triples or...

2012-02-01 23:40:08

UCSF discovery sheds light on how robust exercise may lower the risk of prostate cancer progression Scientists at the University of California, San Francisco (UCSF) have identified nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that may help explain how physical activity improves survival from the disease. The study compared the activity of some 20,000 genes in healthy prostate tissue biopsied from several dozen patients. The finding builds on...

2012-01-25 04:45:31

Among women with invasive epithelial ovarian cancer, patients having a germline (gene change in a reproductive cell that could be passed to offspring) mutation in the BRCA1 or BRCA2 genes was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to a study in the January 25 issue of JAMA. "Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 are the strongest known genetic risk factors for both breast and epithelial ovarian...

Regular Prostate Screenings Won't Reduce Cancer-Related Death Risk
2012-01-07 06:30:48

Researchers from the Washington University School of Medicine in St. Louis claim to have discovered new evidence suggesting that obtaining an annual prostate cancer screening does not reduce mortality rate associated with the disease in older men. The study, which was published online in the Journal of the National Cancer Institute (JNCI) on Friday, looked at approximately 76,000 men between the ages of 55 and 74 participating in the Prostate, Lung, Cancer, Colorectal and Ovarian (PLCO)...

2011-12-16 08:51:08

(Ivanhoe Newswire) — The U.S. Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), and many debated which PSA level should lead to biopsy recommendation. The US Preventive Screening Task Force (USPSTF) recently concluded, amid considerable controversy, that the evidence does not support recommending PSA screening for men under 75 years old at all, because the risks outweigh the benefits. Now, a study shows that physicians in a...

2011-12-13 14:53:29

No movement toward more aggressive follow-up, study in American Journal of Preventive Medicine finds After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation. The US Preventive Screening Task Force (USPSTF) recently concluded, amid considerable controversy, that the evidence does not support recommending PSA screening for men under 75 years old at all,...

2011-12-12 13:25:40

Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study by researchers at the North Shore-LIJ Health System's Monter Cancer Center in Lake Success, NY. The findings were reported on Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium. Iuliana Shapira, MD, North director of cancer genetics, and her colleagues conducted...

2011-12-02 01:39:15

Two studies available in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, have uncovered limitations in screening for primary liver cancer, also known as hepatocellular carcinoma (HCC). The first study found that, if given the choice during a clinical trial, most patients with cirrhosis prefer surveillance over the possibility of non-screening, therefore making a randomized study of HCC screening not feasible. A second study determined...

2011-11-17 03:28:00

Tumors can grow for 10 years or longer before currently available blood tests will detect them, a new mathematical model developed by Stanford University School of Medicine scientists indicates. The analysis, which was restricted to ovarian tumors but is broadly applicable across all solid tumor types, will be published online Nov. 16 in Science Translational Medicine. "The study's results can be viewed as both bad and good news," said Sanjiv "Sam" Gambhir, MD, PhD, professor and chair of...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.